Medicine & Life Sciences
Acute Myeloid Leukemia
48%
Allogeneic Cells
74%
Antigens
18%
B-Lymphocytes
19%
BK Virus
16%
Blood Cells
15%
Busulfan
22%
Cell Transplantation
34%
Cell- and Tissue-Based Therapy
53%
Chimeric Antigen Receptors
88%
Cyclophosphamide
21%
Cytogenetics
27%
Cytokine Release Syndrome
16%
Cytomegalovirus
18%
Fetal Blood
78%
fludarabine
16%
GATA2 Deficiency
17%
Graft vs Host Disease
66%
Haploidentical Transplantation
18%
Hematologic Neoplasms
29%
Hematopoietic Stem Cell Transplantation
49%
Hematopoietic Stem Cells
18%
Imatinib Mesylate
21%
Immunotherapy
45%
Interleukin-15
14%
KIR Receptors
21%
Leukemia
51%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
55%
Leukemia, Myeloid, Chronic Phase
15%
Mortality
15%
Multiple Myeloma
21%
Myeloid Leukemia
21%
Natural Killer Cells
100%
Neoplasms
33%
Peptides
15%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23%
Progression-Free Survival
19%
Protein-Tyrosine Kinases
15%
Recurrence
31%
Regulatory T-Lymphocytes
21%
Stem Cell Transplantation
71%
Stem Cells
29%
Survival
34%
T-Lymphocytes
86%
Therapeutics
19%
Tissue Donors
55%
Transplantation
56%
Transplants
72%
Unrelated Donors
28%
Vaccination
17%